30 days of continuous olanzapine infusion determines energy imbalance, glucose intolerance, insulin resistance, and dyslipidemia in mice.

Source:http://linkedlifedata.com/resource/pubmed/id/19910724

Download in:

View as

General Info

PMID
19910724